Gene expression profiling of the tumor microenvironment during breast cancer progression.

Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun (2013) 2.94

Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest (2011) 2.62

Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med (2010) 2.26

The microenvironment in breast cancer progression: biology and implications for treatment. Breast Cancer Res (2011) 2.22

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer (2010) 2.13

The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol (2010) 2.03

Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer (2014) 2.00

Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res (2010) 1.95

Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots. Clin Cancer Res (2011) 1.91

LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res (2013) 1.91

What is the malignant nature of human ductal carcinoma in situ? Nat Rev Cancer (2010) 1.86

Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci (2013) 1.81

Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res (2011) 1.80

Breast cancer - one term, many entities? J Clin Invest (2011) 1.72

The molecular pathology of breast cancer progression. J Pathol (2010) 1.65

System-wide analysis reveals a complex network of tumor-fibroblast interactions involved in tumorigenicity. PLoS Genet (2013) 1.59

Emerging targeted agents in metastatic breast cancer. Nat Rev Clin Oncol (2013) 1.59

The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone. Cancer Cell (2015) 1.55

LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res (2011) 1.54

Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma. Cell Cycle (2013) 1.52

Breast and prostate cancer: more similar than different. Nat Rev Cancer (2010) 1.48

Identification of early molecular markers for breast cancer. Mol Cancer (2011) 1.45

Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model. J Pathol (2011) 1.43

Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers. Cell Adh Migr (2012) 1.41

Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc Natl Acad Sci U S A (2010) 1.41

An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis. Cancer Res (2010) 1.39

Stroma in breast development and disease. Semin Cell Dev Biol (2009) 1.36

Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival. PLoS One (2010) 1.35

Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J Mammary Gland Biol Neoplasia (2010) 1.32

p38MAPK plays a crucial role in stromal-mediated tumorigenesis. Cancer Discov (2014) 1.27

Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res (2012) 1.23

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity. Front Immunol (2013) 1.22

Clinical management of breast cancer heterogeneity. Nat Rev Clin Oncol (2015) 1.22

Senescence and the pro-tumorigenic stroma. Crit Rev Oncog (2013) 1.16

Molecular markers for the diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst Monogr (2010) 1.15

Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate. Oncogene (2011) 1.14

Comprehensive functional annotation of seventy-one breast cancer risk Loci. PLoS One (2013) 1.10

Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer. PLoS One (2011) 1.10

Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model. PLoS One (2012) 1.09

Preinvasive breast cancer. Annu Rev Pathol (2010) 1.08

Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression. Am J Pathol (2009) 1.07

Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PLoS One (2013) 1.07

Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics. J Natl Cancer Inst Monogr (2010) 1.06

Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium. Clin Cancer Res (2010) 1.05

RORα suppresses breast tumor invasion by inducing SEMA3F expression. Cancer Res (2012) 1.04

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells. Elife (2014) 1.03

Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment. Clin Cancer Res (2012) 1.03

Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Breast Cancer Res (2012) 1.03

In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol Cell Proteomics (2010) 1.03

Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion. Oncoscience (2014) 1.02

An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity. Cell Adh Migr (2012) 0.99

Gene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma. J Biomed Biotechnol (2011) 0.98

Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Res (2013) 0.98

Active roles of tumor stroma in breast cancer metastasis. Int J Breast Cancer (2012) 0.98

Minimising immunohistochemical false negative ER classification using a complementary 23 gene expression signature of ER status. PLoS One (2010) 0.97

Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer. Expert Rev Mol Diagn (2011) 0.97

Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure. BMC Cancer (2015) 0.96

Ion channels expression and function are strongly modified in solid tumors and vascular malformations. J Transl Med (2016) 0.96

FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7. Oncotarget (2013) 0.96

Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res (2013) 0.95

Stromal cells and integrins: conforming to the needs of the tumor microenvironment. Neoplasia (2009) 0.95

Breast tumour stroma is a prognostic indicator and target for therapy. Breast Cancer Res (2009) 0.94

Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer. Nat Cell Biol (2015) 0.94

A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer. Clin Cancer Res (2013) 0.94

miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions. PLoS One (2014) 0.94

Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer. PLoS One (2013) 0.93

A taxonomy of epithelial human cancer and their metastases. BMC Med Genomics (2009) 0.93

Bone Morphogenetic Proteins stimulate mammary fibroblasts to promote mammary carcinoma cell invasion. PLoS One (2013) 0.93

Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse. Mol Cell Proteomics (2012) 0.92

The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation. Mol Cancer (2014) 0.92

Invoking the power of thrombospondins: regulation of thrombospondins expression. Matrix Biol (2014) 0.92

Multiscale models of breast cancer progression. Ann Biomed Eng (2012) 0.91

Functional screen of paracrine signals in breast carcinoma fibroblasts. PLoS One (2012) 0.91

Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev (2016) 0.91

The Six1 oncoprotein downregulates p53 via concomitant regulation of RPL26 and microRNA-27a-3p. Nat Commun (2015) 0.90

Laser capture microdissection for protein and NanoString RNA analysis. Methods Mol Biol (2013) 0.90

MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer. Sci Rep (2015) 0.89

Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer. Breast Cancer Res (2009) 0.89

Cancer stem cell subsets and their relationships. J Transl Med (2011) 0.89

The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches. PLoS One (2014) 0.89

Differential gene expression in normal and transformed human mammary epithelial cells in response to oxidative stress. Free Radic Biol Med (2011) 0.88

Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model. Cancer Cell Int (2015) 0.88

Similarity of markers identified from cancer gene expression studies: observations from GEO. Brief Bioinform (2013) 0.87

Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity. Mol Cancer Ther (2014) 0.87

Roles of microRNA-140 in stem cell-associated early stage breast cancer. World J Stem Cells (2014) 0.87

A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity. Breast Cancer Res (2014) 0.86

Integration of molecular profiling and chemical imaging to elucidate fibroblast-microenvironment impact on cancer cell phenotype and endocrine resistance in breast cancer. PLoS One (2014) 0.86

Stromal biomarkers in breast cancer development and progression. Clin Exp Metastasis (2012) 0.86

ASPN and GJB2 Are Implicated in the Mechanisms of Invasion of Ductal Breast Carcinomas. J Cancer (2012) 0.86

Tumor intrinsic subtype is reflected in cancer-adjacent tissue. Cancer Epidemiol Biomarkers Prev (2014) 0.86

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis. Onco Targets Ther (2016) 0.86

What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us? BMC Med (2011) 0.86

Biomimetic tumor microenvironment on a microfluidic platform. Biomicrofluidics (2013) 0.86

Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cells. PLoS One (2011) 0.85

Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research. Virchows Arch (2012) 0.85

Moving H5N1 studies into the era of systems biology. Virus Res (2013) 0.84

Prognostic stromal gene signatures in breast cancer. Breast Cancer Res (2015) 0.84

Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration. BMC Cancer (2015) 0.84

Extensive rewiring of epithelial-stromal co-expression networks in breast cancer. Genome Biol (2015) 0.84

Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models. Breast Cancer Res (2015) 0.83

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res (2002) 76.95

[''R"--project for statistical computing]. Ugeskr Laeger (2008) 41.69

Involvement of chemokine receptors in breast cancer metastasis. Nature (2001) 26.07

New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer (2002) 24.71

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell (2005) 18.20

Putting tumours in context. Nat Rev Cancer (2001) 12.37

Stromal gene expression predicts clinical outcome in breast cancer. Nat Med (2008) 10.68

Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 10.57

Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell (2004) 9.41

The microenvironment of the tumour-host interface. Nature (2001) 9.17

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell (2004) 8.06

GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics (2007) 6.63

Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med (2007) 6.47

Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A (2003) 6.35

limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics (2004) 6.04

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood (2005) 5.21

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (1991) 5.13

Regulation of in situ to invasive breast carcinoma transition. Cancer Cell (2008) 4.46

Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet (2005) 4.33

Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol (2004) 3.99

SPARC and tumor growth: where the seed meets the soil? J Cell Biochem (2004) 2.75

Mitochondrial defects in cancer. Mol Cancer (2002) 2.75

Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A (2006) 2.72

Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer (2001) 2.71

Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res (2006) 2.36

WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene (2001) 2.32

WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol (2003) 2.30

Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res (2006) 2.12

Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer. Cancer Res (2006) 1.99

Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol (2004) 1.95

The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol (2006) 1.95

Inhibition of c-Myc activity by ribosomal protein L11. EMBO J (2007) 1.78

Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res (2004) 1.76

The IKK-related kinases: from innate immunity to oncogenesis. Cell Res (2008) 1.71

Classification of ductal carcinoma in situ by gene expression profiling. Breast Cancer Res (2006) 1.59

The fibroblastic coconspirator in cancer progression. Cold Spring Harb Symp Quant Biol (2005) 1.56

Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci U S A (2001) 1.55

Transcriptional program induced by Wnt protein in human fibroblasts suggests mechanisms for cell cooperativity in defining tissue microenvironments. PLoS One (2007) 1.50

Differential expression of ribosomal proteins in human normal and neoplastic colorectum. J Histochem Cytochem (2003) 1.36

Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells. Int J Cancer (2008) 1.35

Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem (2008) 1.24

Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. Cancer Res (2008) 1.14

Activin, inhibin and the human breast. Mol Cell Endocrinol (2004) 1.10

Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene (2008) 1.08

Targeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling. Expert Opin Ther Targets (2007) 0.97

Tumor microenvironments, the immune system and cancer survival. Genome Biol (2005) 0.93

Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis. Oncol Rep (2005) 0.87

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell (2005) 18.20

Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell (2008) 11.24

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell (2004) 8.06

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A (2006) 8.01

Sequence analysis of mutations and translocations across breast cancer subtypes. Nature (2012) 7.76

Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A (2003) 6.35

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol (2010) 5.50

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc Natl Acad Sci U S A (2006) 5.23

Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol (2003) 4.25

Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials. J Clin Oncol (2005) 4.04

The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A (2006) 3.64

Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol (2006) 3.33

Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat Genet (2012) 2.71

Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity. J Neurosci (2003) 2.60

Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med (2006) 2.53

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen. Clin Cancer Res (2006) 2.27

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol (2006) 2.24

A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas. Clin Cancer Res (2011) 2.24

NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. J Natl Compr Canc Netw (2011) 2.24

A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Clin Cancer Res (2008) 2.16

Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR. Clin Cancer Res (2005) 1.97

Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev (2002) 1.97

Spindle cell oncocytoma of the adenohypophysis: report of two cases. Acta Neuropathol (2005) 1.81

Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas. Clin Cancer Res (2006) 1.75

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol (2005) 1.69

Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection. J Clin Endocrinol Metab (2007) 1.68

Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS One (2010) 1.68

The molecular pathology of breast cancer progression. J Pathol (2010) 1.65

Proteomics of human breast ductal carcinoma in situ. Cancer Res (2002) 1.62

Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. J Proteome Res (2004) 1.62

Novel role for PDEF in epithelial cell migration and invasion. Cancer Res (2005) 1.57

Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia. Diabetes (2002) 1.51

Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort. Clin Cancer Res (2008) 1.48

HOXB13 promotes ovarian cancer progression. Proc Natl Acad Sci U S A (2007) 1.46

Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J Biol Chem (2002) 1.41

Case records of the Massachusetts General Hospital. Case 24-2005. A 58-year-old woman with early-stage estrogen-receptor-positive breast cancer. N Engl J Med (2005) 1.40

Utility of DNA repair protein foci for the detection of putative BRCA1 pathway defects in breast cancer biopsies. Mol Cancer Res (2009) 1.37

G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. Mol Cell Biol (2005) 1.35

Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner. Genes Dev (2012) 1.30

The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer. Clin Cancer Res (2007) 1.26

The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway. Proc Natl Acad Sci U S A (2011) 1.24

Analysis of the effect of various decalcification agents on the quantity and quality of nucleic acid (DNA and RNA) recovered from bone biopsies. Ann Diagn Pathol (2013) 1.23

Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis. Cancer Res (2006) 1.19

Predisposition to cancer caused by genetic and functional defects of mammalian Atad5. PLoS Genet (2011) 1.18

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. Cancer Res (2010) 1.13

Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). Breast Cancer Res Treat (2013) 1.10

Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer (2007) 1.09

Implementation of a novel microarray-based diagnostic test for cancer of unknown primary. Int J Cancer (2009) 1.03

In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol Cell Proteomics (2010) 1.03

Laser capture microdissection and advanced molecular analysis of human breast cancer. J Mammary Gland Biol Neoplasia (2003) 1.01

Laser capture microdissection of human pancreatic beta-cells and RNA preparation for gene expression profiling. Methods Mol Biol (2009) 1.00

A Rap GTPase interactor, RADIL, mediates migration of neural crest precursors. Genes Dev (2007) 0.98

Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers. PLoS Comput Biol (2008) 0.97

The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials. Breast Cancer Res (2013) 0.97

In situ gene expression analysis of cancer using laser capture microdissection, microarrays and real time quantitative PCR. Cancer Biol Ther (2002) 0.97

Allergic fungal sinusitis: expanding the clinicopathologic spectrum. Otolaryngol Head Neck Surg (2004) 0.96

Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease. J Neurol (2012) 0.96

Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance. Clin Cancer Res (2008) 0.95

Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse. Mol Cell Proteomics (2012) 0.92

Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury. Am J Respir Crit Care Med (2008) 0.92

p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy. Breast Cancer Res (2006) 0.92

Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest. J Neurooncol (2012) 0.90

Smoking in college freshmen: University Project of the Tobacco Etiology Research Network (U pTERN). Nicotine Tob Res (2007) 0.90

Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2. Cancer Res (2002) 0.90

Microproteomic analysis of 10,000 laser captured microdissected breast tumor cells using short-range sodium dodecyl sulfate-polyacrylamide gel electrophoresis and porous layer open tubular liquid chromatography tandem mass spectrometry. J Chromatogr A (2011) 0.87

Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A. PLoS One (2013) 0.87

Memory for famous faces and the temporal pole: functional imaging findings in temporal lobe epilepsy. Epilepsy Behav (2006) 0.87

A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity. Breast Cancer Res (2014) 0.86

HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease. Breast Cancer Res (2013) 0.86

Fine needle aspiration cytology of minor salivary gland tumours of the palate. Cytopathology (2002) 0.86

Laser Capture Microdissection: a rising tool in genetic profiling of cancer. Expert Rev Mol Diagn (2004) 0.86

Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants. Mod Pathol (2012) 0.86

Re-evaluating early breast neoplasia. Breast Cancer Res (2008) 0.85

Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling. Am J Pathol (2013) 0.84

Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males. J Clin Invest (2014) 0.84

Greater extent of resection improves ganglioglioma recurrence-free survival in children: a volumetric analysis. Neurosurgery (2014) 0.83

Bigenic connexin mutations in a patient with hidrotic ectodermal dysplasia. Eur J Dermatol (2005) 0.82

Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer. Breast Cancer Res Treat (2014) 0.80

Associations between sleep and cortisol responses to stress in children and adolescents: a pilot study. Behav Sleep Med (2005) 0.80

Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen. Mod Pathol (2008) 0.79

Prevalence and functional analysis of sequence variants in the ATR checkpoint mediator Claspin. Mol Cancer Res (2009) 0.79

Identification of genes with differential regulation in primate endometrium during the proliferative and secretory phases of the cycle. Endocr Res (2003) 0.78

Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas. BMC Med Genomics (2014) 0.78

VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res (2014) 0.78

Induction of stable drug resistance in human breast cancer cells using a combinatorial zinc finger transcription factor library. PLoS One (2011) 0.77

Moving towards multiple site outcomes in spinal cord injury pain clinical trials: An issue of clustered observations in trial design and analysis. J Spinal Cord Med (2013) 0.77

BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Neuro Oncol (2013) 0.76

Rethinking pediatric gliomas as developmental brain abnormalities. Curr Top Dev Biol (2011) 0.76

Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1. BMC Cancer (2014) 0.76

IgG4 overexpression is rare in meningiomas with a prominent inflammatory component: a review of 16 cases. Brain Pathol (2014) 0.75